07:00 , Aug 12, 2013 |  BC Week In Review  |  Financial News

Vaxart completes venture financing

Vaxart Inc. , San Francisco, Calif.   Business: Infectious   Date completed: 7/24/13   Type: Venture financing   Raised: $20 million   Investors: Care Capital; Quantum Technology Partners; Life Science Angels; Sand Hill Angels; Bay...
23:38 , Aug 7, 2013 |  BC Extra  |  Financial News

Vaxart raises $20 million in C round

Oral vaccine company Vaxart Inc. (San Francisco, Calif.) raised $20 million in a series C round led by existing investor Care Capital. Existing investors Quantum Technology Fund; Life Science Angels; Sand Hill Angels; and Bay...
08:00 , Mar 8, 2010 |  BC Week In Review  |  Financial News

Vaxart completes venture financing

Vaxart Inc. , San Francisco, Calif.   Business: Infectious   Date completed: 3/4/10   Type: Venture financing   Raised: $12.5 million   Investors: Care Capital; Quantum Fund; Life Science Angel Investors; Sand Hill Angels; Bay...
02:20 , Mar 5, 2010 |  BC Extra  |  Financial News

Vaxart raises $12.5 million

Vaxart Inc. (San Francisco, Calif.) raised $12.5 million in a series B round led by new investor Care Capital. Existing investors Quantum Technology Fund; Life Science Angels; Sand Hill Angels; Bay Partners; and undisclosed individuals...
08:00 , Nov 10, 2008 |  BioCentury  |  Finance

Ebb & Flow

In the largest biotech venture financing this year, cancer stem cell antibody company OncoMed received the $93 million final tranche of a B round that totaled $154 million. New investor Nomura Phase4 participated in the...
02:40 , Nov 5, 2008 |  BC Extra  |  Top Story

OncoMed raises $93 million

OncoMed (Redwood City, Calif.) raised $93 million in the final tranche of a series B round, bringing the total raised in the round to $154 million. New investor Nomura Phase4 participated in the financing along...